Mitch Sayare is the founder of ImmunoGen. ImmunoGen has raised $300M in total funding. Latest round: IPO. Based in Waltham, United States.
Mitch Sayare was the co-founder, Chairman, and CEO of ImmunoGen, a publicly traded biotechnology company focused on the development of anti-cancer drugs. He led a successful IPO and raised over $300 million in venture capital and public equity financing for the company. ImmunoGen's first FDA-approved product, Kadcyla, is used for the treatment of Her2-positive breast cancer. Prior to ImmunoGen, he was Vice President, Development at Xenogen, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library